Showing results (391-400 of 600) with videos related to

Sort By:
Pageof 60
Diabetologia|February 28, 2025
Targeted serum proteomics of longitudinal samples from newly diagnosed youth with type 1 diabetes affirms markers of diseaseRobert Moulder, M Karoliina Hirvonen, Tommi Välikangas, et al.
Immunology Letters|July 6, 2010
Murine bone marrow chimeras developing autoimmunity after CTLA-4-blockade show an expansion of T regulatory cells with an activated cytokine profileLien De Somer, Sabine Fevery, Dominique M A Bullens, et al.
Lancet (London, England)|March 15, 2011
Insulin degludec, an ultra-long-acting basal insulin, once a day or three times a week versus insulin glargine once a day in patients with type 2 diabetes: a 16-week, randomised, open-label, phase 2 trialBernard Zinman, Greg Fulcher, Paturi V Rao, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|May 14, 2013
Treatment outcomes after initiation of exenatide twice daily or insulin in clinical practice: 12-month results from CHOICE in six European countriesClaes-Göran Ostenson, Stephan Matthaei, Matthew Reaney, et al.
Clinicoeconomics and Outcomes Research : CEOR|July 23, 2013
Resource use and costs of exenatide bid or insulin in clinical practice: the European CHOICE studyUrpo Kiiskinen, Stephan Matthaei, Matthew Reaney, et al.
Diabetologia|May 9, 2015
A proposal for the use of uniform diagnostic criteria for gestational diabetes in Europe: an opinion paper by the European Board & College of Obstetrics and Gynaecology (EBCOG)Katrien Benhalima, Chantal Mathieu, Peter Damm, et al.
Diabetes Technology & Therapeutics|September 24, 2009
Two-year efficacy and safety of AIR inhaled insulin in patients with type 1 diabetes: An open-label randomized controlled trialSatish K Garg, Chantal Mathieu, Nadeem Rais, et al.
The Lancet. Diabetes & Endocrinology|October 7, 2023
Precision medicine for cardiometabolic disease: a framework for clinical translationPaul W Franks, William T Cefalu, John Dennis, et al.
Trials|May 18, 2022
INNODIA Master Protocol for the evaluation of investigational medicinal products in children, adolescents and adults with newly diagnosed type 1 diabetesDavid B Dunger, Sylvaine F A Bruggraber, Adrian P Mander, et al.
Diabetes|September 11, 2014
Citrullinated glucose-regulated protein 78 is an autoantigen in type 1 diabetesDieter Rondas, Inne Crèvecoeur, Wannes D'Hertog, et al.
Pageof 60